Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
22.09
+0.78 (3.66%)
Mar 5, 2026, 10:32 AM EST - Market open
Sutro Biopharma Employees
Sutro Biopharma had 310 employees as of December 31, 2024. The number of employees increased by 8 or 2.65% compared to the previous year.
Employees
310
Change (1Y)
8
Growth (1Y)
2.65%
Revenue / Employee
$593,517
Profits / Employee
-$1,217,792
Market Cap
362.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 172 |
| Nautilus Biotechnology | 124 |
| Foghorn Therapeutics | 112 |
| Neurogene | 107 |
| Rezolute | 75 |
| Immuneering | 54 |
| Protara Therapeutics | 33 |
| Avalo Therapeutics | 23 |
STRO News
- 8 days ago - Sutro Biopharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering - GlobeNewsWire
- 6 weeks ago - Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 months ago - Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript - Seeking Alpha
- 4 months ago - Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 - GlobeNewsWire
- 4 months ago - Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference - GlobeNewsWire
- 5 months ago - Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones - GlobeNewsWire